| scholarly article | Q13442814 |
| P2093 | author name string | D E Stewart | |
| S Abbey | |||
| E J Heathcote | |||
| K Cauch-Dudek | |||
| P2860 | cites work | A rating scale for depression | Q24564540 |
| “Mini-mental state” | Q25938989 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 | ||
| Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites | Q34255972 | ||
| Psychiatric disorders and medical care utilization among people in the general population who report fatigue | Q34358377 | ||
| The epidemiology of chronic fatigue syndrome | Q34367239 | ||
| Population based study of fatigue and psychological distress | Q36884579 | ||
| Definition and measurement of fatigue | Q37704082 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviors | Q43326124 | ||
| The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model | Q44358498 | ||
| The demography of primary biliary cirrhosis in Ontario, Canada | Q44439436 | ||
| Psychosocial problems among survivors of Hodgkin's disease | Q44475931 | ||
| Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome | Q44929071 | ||
| Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. | Q45773559 | ||
| Prognosis in primary biliary cirrhosis: model for decision making | Q46316848 | ||
| The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis | Q49110706 | ||
| One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. | Q50987902 | ||
| Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. | Q52091345 | ||
| The measurement of fatigue: A new instrument | Q60627509 | ||
| A study of fatigue in systemic lupus erythematosus | Q68652316 | ||
| The epidemiology of self-perceived fatigue among adults | Q69528878 | ||
| The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 | ||
| The problem of fatigue in dialysis patients | Q70435305 | ||
| Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis | Q71035932 | ||
| Hamilton Depression Rating Scale. Extracted from Regular and Change Versions of the Schedule for Affective Disorders and Schizophrenia | Q71465922 | ||
| Fatigue associated with chronic liver disease: A riddle wrapped in a mystery inside an enigma | Q71818804 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 705-710 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Fatigue in primary biliary cirrhosis | |
| P478 | volume | 43 |
| Q35875673 | A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome |
| Q46509129 | A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue |
| Q84476629 | American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis |
| Q33903556 | An association between unrecognized gastroesophageal reflux disease and excessive daytime sleepiness in Taiwanese subjects suspected to have liver disease: a pilot study. |
| Q79770376 | Assessing quality of life in primary biliary cirrhosis |
| Q54973746 | Assessment and Management of Sleep Disturbance in Cirrhosis. |
| Q42409638 | Association between fatigue and decreased survival in primary biliary cirrhosis |
| Q34111559 | Autoantigens in primary biliary cirrhosis |
| Q37355570 | Autonomic dysfunction in chronic liver disease. |
| Q51697910 | Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology. |
| Q35068031 | Current management of primary biliary cirrhosis and primary sclerosing cholangitis |
| Q38948929 | Demonstration of two types of fatigue in subjects with chronic liver disease using factor analysis |
| Q34427089 | Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis |
| Q35598197 | Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study |
| Q36119487 | Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy |
| Q35596429 | Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. |
| Q47694027 | Fatigue as a major predictor of quality of life in women with autoimmune liver disease: the case of primary biliary cirrhosis |
| Q35956377 | Fatigue complicating chronic liver disease |
| Q38201591 | Fatigue in advanced kidney disease |
| Q34769039 | Fatigue in cholestatic liver disease--a perplexing symptom |
| Q43005119 | Fatigue in chronic cholestasis |
| Q36426862 | Fatigue in liver disease: pathophysiology and clinical management |
| Q34114608 | Fatigue in primary biliary cirrhosis |
| Q48496394 | Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence |
| Q45279412 | Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat. |
| Q53221825 | Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial. |
| Q24793791 | Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634] |
| Q35760389 | Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort |
| Q31924163 | Increased midbrain 5-HT1A receptor number and responsiveness in cholestatic rats |
| Q35182259 | Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence |
| Q55498617 | Magnetic resonance imaging evidence of hippocampal structural changes in patients with primary biliary cholangitis. |
| Q26744541 | Managing Sleep Disturbances in Cirrhosis |
| Q46552210 | Methodological issues and the measurement of fatigue in primary biliary cirrhosis |
| Q33868631 | Muscle fatigue in women with primary biliary cirrhosis: Spectral analysis of surface electromyography. |
| Q55202763 | NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid. |
| Q37355843 | Natural history and management of primary biliary cirrhosis |
| Q35573903 | Natural history of primary biliary cirrhosis. |
| Q60584959 | Neural Indicators of Fatigue in Chronic Diseases: A Systematic Review of MRI Studies |
| Q33927942 | Nighttime sleep and daytime functioning (sleepiness and fatigue) in well-defined chronic rheumatic diseases |
| Q53190185 | Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. |
| Q35134708 | Predicting Fatigue in Patients Using Home Parenteral Nutrition: A Longitudinal Study |
| Q38651060 | Primary Biliary Cholangitis Alters Functional Connections of the Brain's Deep Gray Matter |
| Q36429706 | Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure |
| Q64234658 | Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions |
| Q56854243 | Primary biliary cirrhosis |
| Q84230884 | Primary biliary cirrhosis |
| Q21202919 | Primary biliary cirrhosis |
| Q36599248 | Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis |
| Q34170438 | Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis |
| Q26799419 | Primary biliary cirrhosis: From bench to bedside |
| Q26853649 | Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy |
| Q33869324 | Primary biliary cirrhosis: new perspectives in diagnosis and treatment |
| Q35894578 | Primary biliary cirrhosis: report of a focus study group |
| Q35573894 | Primary biliary cirrhosis—presentation and diagnosis |
| Q35573916 | Pruritus and fatigue in primary biliary cirrhosis |
| Q34599792 | Psychiatric disorders and mental health service use among caregivers of advanced cancer patients |
| Q45059665 | Quality of life in patients with primary biliary cirrhosis |
| Q82068602 | Sickness behaviors in chronic cholestasis: an immune-mediated process? |
| Q82068670 | TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice |
| Q52624982 | The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. |
| Q47999579 | The association between chronic diseases and fatigue in the working population. |
| Q54976907 | The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. |
| Q42923603 | The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Results of a 9year follow-up |
| Q24792938 | The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis |
| Q43589988 | The specificity of fatigue in primary biliary cirrhosis: evaluation of a large clinic practice |
| Q24202184 | Ursodeoxycholic acid for primary biliary cirrhosis |
| Q24241945 | Ursodeoxycholic acid for primary biliary cirrhosis |
| Q52920374 | Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. |
Search more.